K. Ihara, E. Ishii, and M. Eguchi, Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia, Proceedings of the National Academy of Sciences, vol.55, issue.16, pp.3132-3136, 1999.
DOI : 10.1111/j.1651-2227.1970.tb08986.x

M. Bennett and D. Stroncek, Recent advances in the bcr-abl negative chronic myeloproliferative diseases, Journal of Translational Medicine, vol.4, issue.1, p.41, 2006.
DOI : 10.1186/1479-5876-4-41

X. He, Z. Chen, Y. Jiang, X. Qiu, and X. Zhao, Different mutations of the human c-mpl gene indicate distinct haematopoietic diseases, Journal of Hematology & Oncology, vol.6, issue.1, p.11, 2013.
DOI : 10.1007/s12185-009-0413-3

M. Tijssen, F. Di-summa, and S. Van-den-oudenrijn, Functional analysis of single amino-acid mutations in the thrombopoietin-receptor Mpl underlying congenital amegakaryocytic thrombocytopenia, British Journal of Haematology, vol.35, issue.6, pp.808-813, 2008.
DOI : 10.1073/pnas.96.14.8126

L. Varghese, J. Zhang, and S. Young, Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia, Growth Factors, vol.315, issue.1, pp.18-26, 2014.
DOI : 10.1006/jmbi.2001.5243

C. Stockklausner, A. Klotter, and N. Dickemann, The thrombopoietin receptor P106L mutation functionally separates receptor signaling activity from thrombopoietin homeostasis, Blood, vol.125, issue.7, pp.1159-1169, 2015.
DOI : 10.1182/blood-2014-07-587170

URL : http://www.bloodjournal.org/content/bloodjournal/125/7/1159.full.pdf

A. Moliterno, D. Williams, L. Gutierrez-alamillo, R. Salvatori, R. Ingersoll et al., Mpl Baltimore: A thrombopoietin receptor polymorphism associated with thrombocytosis, Proceedings of the National Academy of Sciences, vol.93, issue.2, pp.11444-11447, 2004.
DOI : 10.1073/pnas.0401496101

URL : http://www.pnas.org/content/101/31/11444.full.pdf

L. Han, C. Schubert, K. ¨. , and J. , Calreticulin-mutant proteins induce megakaryocytic signaling to transform hematopoietic cells and undergo accelerated degradation and Golgi-mediated secretion, Journal of Hematology & Oncology, vol.59, issue.Pt 5, p.45, 2016.
DOI : 10.1016/0092-8674(89)90019-6

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894373

I. Chachoua, C. Pecquet, and M. El-khoury, Thrombopoietin receptor activation by myeloproliferative neoplasm associated calreticulin mutants, Blood, vol.127, issue.10, pp.1325-1335, 2016.
DOI : 10.1182/blood-2015-11-681932

URL : http://www.bloodjournal.org/content/bloodjournal/127/10/1325.full.pdf

X. Lu, R. Levine, and W. Tong, Expression of a homodimeric type I cytokine receptor is required for JAK2V617F-mediated transformation, Proceedings of the National Academy of Sciences, vol.14, issue.1, pp.18962-18967, 2005.
DOI : 10.1093/protein/14.1.27

C. Cleyrat, M. Vilaine, and M. Boissinot, Surface expression of Mpl: aberrant Mpl trafficking in myeloproliferafive neoplasms is linked to insufficient expression of wild type Jak2, Blood, vol.118, issue.21, 2011.

W. Tong, R. Sulahian, A. Gross, N. Hendon, H. Lodish et al., The Membrane-proximal Region of the Thrombopoietin Receptor Confers Its High Surface Expression by JAK2-dependent and -independent Mechanisms, Journal of Biological Chemistry, vol.266, issue.50, pp.38930-38940, 2006.
DOI : 10.1042/0264-6021:3610105

C. Cleyrat, A. Darehshouri, and M. Steinkamp, Mpl Traffics to the Cell Surface Through Conventional and Unconventional Routes, Traffic, vol.19, issue.9, pp.961-982, 2014.
DOI : 10.1093/emboj/19.21.5720

URL : http://onlinelibrary.wiley.com/doi/10.1111/tra.12185/pdf

M. Germeshausen, M. Ballmaier, and K. Welte, MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease, Human Mutation, vol.27, issue.3, p.296, 2006.
DOI : 10.1002/humu.9415

M. Ballmaier and M. Germeshausen, Congenital Amegakaryocytic Thrombocytopenia: Clinical Presentation, Diagnosis, and Treatment, Seminars in Thrombosis and Hemostasis, vol.37, issue.06, pp.673-681, 2011.
DOI : 10.1055/s-0031-1291377

K. Mahadeo, P. Tewari, and S. Parikh, Durable engraftment and correction of hematological abnormalities in children with congenital amegakaryocytic thrombocytopenia following myeloablative umbilical cord blood transplantation, Pediatric Transplantation, vol.21, issue.7, pp.753-757, 2015.
DOI : 10.1038/sj.bmt.1701147

B. Shui, H. Matias, L. Guo, Y. Peng, and Y. , The Rise of CRISPR/Cas for Genome Editing in Stem Cells, Stem Cells International, vol.16, issue.11, p.8140168, 2016.
DOI : 10.1073/pnas.1314697110

M. Dewitt, W. Magis, and N. Bray, Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells, Science Translational Medicine, vol.12, issue.12, pp.360-134, 2016.
DOI : 10.1186/1471-2105-12-323

I. Dobo, N. Boiret, and E. Lippert, A standardized endogenous megakaryocytic erythroid colony assay for the diagnosis of essential thrombocythemia, Haematologica, vol.89, issue.10, pp.1207-1212, 2004.

W. Chen, Y. B. Zhang, Q. Xu, and P. , Identification of the Residues in the Extracellular Domain of Thrombopoietin Receptor Involved in the Binding of Thrombopoietin and a Nuclear Distribution Protein (Human NUDC), Journal of Biological Chemistry, vol.14, issue.34, pp.26697-26709, 2010.
DOI : 10.1084/jem.185.11.1939

N. Komatsu, M. Kunitama, and M. Yamada, Establishment and characterization of the thrombopoietin-dependent megakaryocytic cell line, UT-7/TPO, Blood, vol.87, issue.11, pp.4552-4560, 1996.

M. Ponpuak, M. Mandell, T. Kimura, S. Chauhan, C. Cleyrat et al., Secretory autophagy, Current Opinion in Cell Biology, vol.35, pp.106-116, 2015.
DOI : 10.1016/j.ceb.2015.04.016

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4529791

C. Richardson, G. Ray, M. Dewitt, G. Curie, and J. Corn, Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA, Nature Biotechnology, vol.69, issue.3, pp.339-344, 2016.
DOI : 10.1016/B978-0-12-801185-0.00001-5

T. Cradick, E. Fine, C. Antico, and G. Bao, CRISPR/Cas9 systems targeting ??-globin and CCR5 genes have substantial off-target activity, Nucleic Acids Research, vol.41, issue.20, pp.9584-9592, 2013.
DOI : 10.1093/nar/gkt714

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3814385

F. Al-qahtani, Congenital Amegakaryocytic Thrombocytopenia: A Brief Review of the Literature, Clinical Medicine Insights: Pathology, vol.3, pp.25-30, 2010.
DOI : 10.4137/CPath.S4972

T. Kim, S. Jung, and M. Kim, The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers, The Journal of Pathology, vol.4, issue.3, pp.365-374, 2014.
DOI : 10.1038/nrc1360

H. Gee, S. Noh, B. Tang, K. Kim, and M. Lee, Rescue of ??F508-CFTR Trafficking via a GRASP-Dependent Unconventional Secretion Pathway, Cell, vol.146, issue.5, pp.746-760, 2011.
DOI : 10.1016/j.cell.2011.07.021

S. Chauhan, Z. Ahmed, and S. Bradfute, Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potential, Nature Communications, vol.8, p.8620, 2015.
DOI : 10.1042/bj3570759

P. Hsu, D. Scott, and J. Weinstein, DNA targeting specificity of RNA-guided Cas9 nucleases, Nature Biotechnology, vol.49, issue.9, pp.827-832, 2013.
DOI : 10.1073/pnas.1019533108

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969858

I. Tasan, S. Jain, and H. Zhao, Use of genome-editing tools to treat sickle cell disease, Human Genetics, vol.118, issue.6, pp.1011-1028, 2016.
DOI : 10.1182/blood-2011-02-335554